GL1X · GenesisL1 explorer

MolNFT v1 · #167707 · protein

Optimization and biological evaluation of thiazole-bis-amide inverse agonists of rorgt

6VSW: “Optimization and biological evaluation of thiazole-bis-amide inverse agonists of rorgt”. X-ray diffraction, 1 ligand (RG7). MolNFT v1 #167707 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6VSW
Type
protein
Length
453 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q6I9R9
Ligands
RG7

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein228—Q6I9R9
B—protein225—Q6I9R9

Ligands and binding sites

  • RG7 · 5-(2,3-dichloro-4-{[(2S)-1,1,1-trifluoropropan-2-yl]sulfamoyl}phenyl)-4-(4-fluoropiperidine-1-carbonyl)-N-(2-hydroxy-2-methylpropyl)-1,3-thiazole-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6VSW · Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORgt · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.